Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Clinical trial NCT07042126 · RECRUITING

Trial details

NCT number: NCT07042126
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2025-08-05
Primary completion: 2026-06-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.